# Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

> **NCT00769587** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire, Amiens**

## Conditions studied

- Non Neoplastic Condition
- Precancerous Condition

## Interventions

- **DRUG:** thalidomide

## Key facts

- **NCT ID:** NCT00769587
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-05
- **Final completion:** 2012-10
- **Target enrollment:** — (—)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769587, "Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00769587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*